Safety and tolerability of etirinotecan pegol in advanced breast cancer: analysis of the randomized, phase 3 BEACON trial
- Cortés, J.
- Rugo, H.S.
- Twelves, C.
- Awada, A.
- Perez, E.A.
- Im, S.-A.
- Zhao, C.
- Hoch, U.
- Tomkinson, D.
- Buchanan, J.
- Tagliaferri, M.
- Hannah, A.
- O’Shaughnessy, J.
Zeitschrift:
SpringerPlus
ISSN: 2193-1801
Datum der Publikation: 2016
Ausgabe: 5
Nummer: 1
Art: Artikel